Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Are bat retroviruses a threat to humans?

Are bat retroviruses a threat to humans?

Self-correcting genetic mutations may protect patients with shortened telomeres from blood cancers

Self-correcting genetic mutations may protect patients with shortened telomeres from blood cancers

“Batman Sam” fights cancer with care from Johns Hopkins Children’s Center

“Batman Sam” fights cancer with care from Johns Hopkins Children’s Center

Study offers important evidence for the safety of stem cell transplants

Study offers important evidence for the safety of stem cell transplants

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

Shorter survival of multiple myeloma subgroup linked to worse kidney damage

Shorter survival of multiple myeloma subgroup linked to worse kidney damage

An existing drug may function as targeted therapy for ALL in children

An existing drug may function as targeted therapy for ALL in children

CIRM approves a trio of awards for new stem cell-based projects

CIRM approves a trio of awards for new stem cell-based projects

Study suggests a novel therapeutic target to reverse lung fibrosis

Study suggests a novel therapeutic target to reverse lung fibrosis

Study illuminates genetic understanding of aggressive childhood leukemias

Study illuminates genetic understanding of aggressive childhood leukemias

Remote controlling of CAR-T cells with heat to precisely target tumors

Remote controlling of CAR-T cells with heat to precisely target tumors

Cancer linked with increased risk of kidney failure

Cancer linked with increased risk of kidney failure

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Specific leukemia gene mutations exert divergent effects on DNA repair and sensitivity to PARP Inhibitors

Specific leukemia gene mutations exert divergent effects on DNA repair and sensitivity to PARP Inhibitors

Researchers develop a new way to tag tumor cells to understand cancer treatment resistance

Researchers develop a new way to tag tumor cells to understand cancer treatment resistance

UC San Diego scientists develop new method to keep cultured cells healthy

UC San Diego scientists develop new method to keep cultured cells healthy

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.